Genetics of "high-risk" chronic lymphocytic leukemia in the times of chemoimmunotherapy

Haematologica. 2020 May;105(5):1180-1182. doi: 10.3324/haematol.2020.246504.

Authors

Alexander Ring¹, Thorsten Zenz¹

Affiliation

¹ Department of Medical Oncology and Haematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Cell Cycle
Genomics
Humans
Immunotherapy
Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell* / genetics
Receptor, Notch1
Rituximab

Substances

NOTCH1 protein, human
Receptor, Notch1
Rituximab